We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Actavis Expands Generics Business With Alpharma Purchase
Actavis Expands Generics Business With Alpharma Purchase
October 21, 2005
Iceland-based drugmaker Actavis has taken another major step to expand its presence in the generics market, announcing Oct. 17 that it plans to purchase Alpharma’s U.S. and international generics businesses for roughly $810 million.